The Medicine Maker | Interviews

Filter by

Development & Clinical Regulation & Standards Business & Trends Technology & Manufacturing Sponsored

From Training Burden to Training Value

August 14, 2026

Why effective study training depends on relevance, timing, and oversight.

0 min read

Drug Discovery Interviews Technology & Manufacturing

Can Exosomes Unlock Nanomedicine’s Regenerative Medicine Potential?

August 12, 2026

NurExone CEO Lior Shaltiel discusses the company’s exosome-based approach to nerve regeneration, the manufacturing hurdles facing the field, and what it will take to bring nanotechnology therapeutics to patients

11 min read

Can Exosomes Unlock Nanomedicine’s Regenerative Medicine Potential?

Cell & Gene Interviews Business & Trends Technology & Manufacturing

Building Commercial Readiness in Advanced Therapies

August 10, 2026

Why early process development, analytical planning, and tech transfer can shape the future of cell and gene therapy manufacturing

5 min read

Building Commercial Readiness in Advanced Therapies

Biopharma Interviews Technology & Manufacturing

Moving Glycosylation Control Upstream

August 6, 2026

Samsung Biologics’ Sojeong Lee discusses why biologics developers are paying closer attention to glycosylation earlier in development.

7 min read

Development & Clinical Future of Pharma Technology & Manufacturing

What Did ASCO 2026 Reveal About the Future of Oncology?

By James Strachan

August 6, 2026

Six drug development leaders discuss smarter immunotherapy combinations, the enduring potential of small molecules, emerging modalities, and how cancer treatment could evolve over the next two decades

8 min read

What Did ASCO 2026 Reveal About the Future of Oncology?

Development & Clinical Biopharma Interviews Business & Trends

How China Is Rewriting the Rules Global Drug Development

By James Strachan

August 5, 2026

In part two of our conversation, Lingshi Tan explores how China’s integrated biopharma ecosystem is reshaping assumptions about speed, cost, innovation, and cross-border clinical development

14 min read

How China Is Rewriting the Rules Global Drug Development

Cell & Gene Cell & Gene Interviews

Single-Cell Analysis Reveals Hidden CAR T Manufacturing Risks

July 23, 2026

Mission Bio’s Mike Molnar explains how single-cell multiomics could improve vector copy number analysis, product characterization, and safety assessment in CAR T development

5 min read

Single-Cell Analysis Reveals Hidden CAR T Manufacturing Risks

Small Molecules Small Molecules Business & Trends Formulation Formulation

Why Drug Development Still Lacks Integration

July 21, 2026

John McDermott reflects on why early drug development remains fragmented – and how integrated approaches may shorten timelines

4 min read

Why Drug Development Still Lacks Integration

Outsourcing Regulation & Standards Biopharma Business & Trends

The Rise of China: From Science Cities to Global Ambition

By James Strachan, Kathryn Wighton

July 15, 2026

Daphne Smyth of Veristat on the rise of Chinese biopharma, regulatory realities, and what comes next

8 min read

The Rise of China: From Science Cities to Global Ambition

Cell & Gene Development & Clinical Business & Trends

Surviving CGT's Funding Winter

By Alun Evans, James Strachan

July 15, 2026

In the first installment of a new series on the investment environment in cell and gene therapy, Circio CEO Erik Wiklund explains how he had to get creative to raise funds in a difficult biotech market

10 min read

Explore

Featured Topics

Issues

Topics

News & Blogs

Community & Awards

Interviews

Filter by

Recommended